Company intelligence / Profile preview

CureLauncher

East Aurora, New York, United States

Ownership: Private
Development stage: Other

Overview

CureLauncher is a digital health company that provides a patient-centric platform designed to connect individuals with clinical trials. The company focuses on humanizing the clinical trial recruitment process by providing personalized support and easy-to-understand information to patients and their families. By streamlining the connection between trial sponsors and participants, CureLauncher helps accelerate medical research and provides patients with access to potentially life-saving treatments. In 2020, the company was acquired by GRYT Health to integrate its matching technology with GRYT's patient community and engagement tools.

Industry: Contract Research Organization

Beyond the preview

Go deeper on CureLauncher.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CureLauncher.

Explore the full profile